KOGEMY Trademark

Trademark Overview

On Friday, February 18, 2022, a trademark application was filed for KOGEMY with the United States Patent and Trademark Office. The USPTO has given the KOGEMY trademark a serial number of 97273875. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, March 5, 2024. This trademark is owned by CORCEPT THERAPEUTICS INCORPORATED. The KOGEMY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations for the treatment of Cushing's syndrome and Cushing's disease; pharmaceutical preparations for the treatment of cancer, liver disorders, oncologic, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders
kogemy

General Information

Serial Number97273875
Word MarkKOGEMY
Filing DateFriday, February 18, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateTuesday, March 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 18, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations for the treatment of Cushing's syndrome and Cushing's disease; pharmaceutical preparations for the treatment of cancer, liver disorders, oncologic, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 23, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCORCEPT THERAPEUTICS INCORPORATED
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMENLO PARK, CA 94025
Party NameCORCEPT THERAPEUTICS INCORPORATED
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMENLO PARK, CA 94025

Trademark Events

Event DateEvent Description
Wednesday, March 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 5, 2024SOU EXTENSION 3 GRANTED
Tuesday, March 5, 2024SOU EXTENSION 3 FILED
Tuesday, March 5, 2024SOU TEAS EXTENSION RECEIVED
Friday, December 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 30, 2023SOU EXTENSION 2 GRANTED
Thursday, November 30, 2023SOU EXTENSION 2 FILED
Thursday, November 30, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, March 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 24, 2023SOU EXTENSION 1 GRANTED
Friday, March 24, 2023SOU EXTENSION 1 FILED
Friday, March 24, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 13, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 21, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 21, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 21, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 18, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 18, 2022PUBLISHED FOR OPPOSITION
Wednesday, September 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 14, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 13, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 12, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 12, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 16, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 16, 2022NON-FINAL ACTION E-MAILED
Wednesday, March 16, 2022NON-FINAL ACTION WRITTEN
Wednesday, March 16, 2022ASSIGNED TO EXAMINER
Wednesday, February 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 22, 2022NEW APPLICATION ENTERED

Related Keywords

kogemy pharmaceutical disorders treatment preparations diseases cushing metabolic oncologic cardiovascular ophthalmic